Warren Olanow – Biography
Last update: March 25, 2026Executive profile
Warren was Interim Chief Medical Officer for Clintrex.
Warren Olanow is currentlyChief Executive Officer of Clintrex Research at Inhibikase Therapeutics - View - Inhibikase Therapeutics org chart
Create your alert
to follow the career of Warren Olanow.
Education
Warren Olanow has a Doctor of Medicine from University of Toronto.
They have also studied at University of Toronto :
Find more alumni from University of Toronto
More about Warren Olanow
Selected links
Do you need to know more about Warren Olanow? More results.
Participate
Social media
- Warren Olanow on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Warren Olanow
The colleagues of Warren Olanow
Company Colleagues
- At Inhibikase Therapeutics, Warren Olanow has 17 colleagues including Mark Iwicki (CEO), Vincent Aurentz (Director)…
Industry Colleagues
- In the Biotechnology industry, Warren Olanow has 35,755 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Warren Olanow.
Get in Touch
Here are a few tips for establishing great contacts.
